These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35592585)

  • 1. Understanding the Effect of the COVID-19 Pandemic on Substance Use Disorder Treatment Facility Operations and Patient Success: Evidence From Mississippi.
    Meadowcroft D; Davis W
    Subst Abuse; 2022; 16():11782218221095872. PubMed ID: 35592585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of COVID-19 on residential treatment programs for substance use disorder.
    Pagano A; Hosakote S; Kapiteni K; Straus ER; Wong J; Guydish JR
    J Subst Abuse Treat; 2021 Apr; 123():108255. PubMed ID: 33375986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID 19-impact on substance use treatment utilization and provision in South Africa.
    Harker N; Johnson K; Erasmus J; Myers B
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):15. PubMed ID: 35241095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical Dilemmas Facing Substance Use Counselors During the COVID-19 Pandemic.
    McCuistian C; Fokuo JK; Dumoit Smith J; Sorensen JL; Arnold EA
    Subst Abuse; 2023; 17():11782218231158338. PubMed ID: 36923068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study.
    Adelekan B; Goldson E; Abubakar Z; Mueller U; Alayande A; Ojogun T; Ntoimo L; Williams B; Muhammed I; Okonofua F
    Reprod Health; 2021 Aug; 18(1):166. PubMed ID: 34348757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abortion service availability during the COVID-19 pandemic: Results from a national census of abortion facilities in the U.S.
    Kaller S; Muñoz MGI; Sharma S; Tayel S; Ahlbach C; Cook C; Upadhyay UD
    Contracept X; 2021; 3():100067. PubMed ID: 34308330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Telehealth Services for Prenatal Care in Mississippi: Comparison of Pre-COVID-19 Pandemic and Pandemic Obstetric Management.
    Reneker JC; Zhang Y; Young DK; Liu X; Lutz EA
    Int J Clin Pract; 2022; 2022():3535700. PubMed ID: 35685499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telehealth Adoption by Mental Health and Substance Use Disorder Treatment Facilities in the COVID-19 Pandemic.
    Cantor J; McBain RK; Kofner A; Hanson R; Stein BD; Yu H
    Psychiatr Serv; 2022 Apr; 73(4):411-417. PubMed ID: 34407631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of Outpatient Telemental Health Services in the United States at the Outset of the COVID-19 Pandemic.
    Cantor JH; McBain RK; Kofner A; Stein BD; Yu H
    Med Care; 2021 Apr; 59(4):319-323. PubMed ID: 33480660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration.
    Timko C; Hoggatt KJ; Wu FM; Tjemsland A; Cucciare M; Rubin A; Simpson TL
    Womens Health Issues; 2017; 27(6):639-645. PubMed ID: 28602581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common themes in early state policy responses to substance use disorder treatment during COVID-19.
    Andraka-Christou B; Bouskill K; Haffajee RL; Randall-Kosich O; Golan M; Totaram R; Gordon AJ; Stein BD
    Am J Drug Alcohol Abuse; 2021 Jul; 47(4):486-496. PubMed ID: 33909518
    [No Abstract]   [Full Text] [Related]  

  • 12. "How can I hug someone now [over the phone]?": Impacts of COVID-19 on peer recovery specialists and clients in substance use treatment.
    Anvari MS; Seitz-Brown CJ; Spencer J; Mulheron M; Abdelwahab S; Borba CPC; Magidson JF; Felton JW
    J Subst Abuse Treat; 2021 Dec; 131():108649. PubMed ID: 34716038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Telehealth in Substance Use Disorder Services During and After COVID-19: Online Survey Study.
    Molfenter T; Roget N; Chaple M; Behlman S; Cody O; Hartzler B; Johnson E; Nichols M; Stilen P; Becker S
    JMIR Ment Health; 2021 Feb; 8(2):e25835. PubMed ID: 33481760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Was the Change in Telehealth Usage and Proportion of No-show Visits for an Orthopaedic Trauma Clinic During the COVID-19 Pandemic?
    Siow MY; Walker JT; Britt E; Kozy JP; Zanzucchi A; Girard PJ; Schwartz AK; Kent WT
    Clin Orthop Relat Res; 2020 Oct; 478(10):2257-2263. PubMed ID: 32639309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the integration of telehealth into the same-day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID-19: a mixed-method analysis of real-world data.
    Amatavete S; Lujintanon S; Teeratakulpisarn N; Thitipatarakorn S; Seekaew P; Hanaree C; Sripanjakun J; Prabjuntuek C; Suwannarat L; Phattanathawornkool T; Photisan N; Suriwong S; Avery M; Mills S; Phanuphak P; Phanuphak N; Ramautarsing RA
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25816. PubMed ID: 34713623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoption of telemedicine services by substance abuse treatment facilities in the U.S.
    Uscher-Pines L; Cantor J; Huskamp HA; Mehrotra A; Busch A; Barnett M
    J Subst Abuse Treat; 2020 Oct; 117():108060. PubMed ID: 32811631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.
    Mauro PM; Furr-Holden CD; Strain EC; Crum RM; Mojtabai R
    Drug Alcohol Depend; 2016 Jun; 163():108-15. PubMed ID: 27106113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco-free grounds implementation in California residential substance use disorder (SUD) treatment programs.
    Guydish J; Wahleithner J; Williams D; Yip D
    J Addict Dis; 2020; 38(1):55-63. PubMed ID: 32186480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
    Paino M; Aletraris L; Roman P
    J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.